Upstream Bio, Inc. (UPB)

5.33 -0.01 (-0.19%) USD  |  NASDAQ  |  Sep 21, 09:56
More

Upstream Bio Total Long Term Debt (Quarterly) : 0.226M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for UPB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 0.226M
March 31, 2026 0.39M
December 31, 2025 0.549M
September 30, 2025 0.703M
Date Value
June 30, 2025 0.849M
March 31, 2025 0.992M
December 31, 2024 1.13M
September 30, 2024 1.263M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Sutro Biopharma, Inc. 243.19M
Compass Therapeutics, Inc. 7.996M
ACADIA Pharmaceuticals, Inc. 59.55M
Alnylam Pharmaceuticals, Inc. 2.942B
Anika Therapeutics, Inc. 23.32M